» Articles » PMID: 29721353

Immunoexcitotoxicity As the Central Mechanism of Etiopathology and Treatment of Autism Spectrum Disorders: A Possible Role of Fluoride and Aluminum

Overview
Journal Surg Neurol Int
Specialty Neurology
Date 2018 May 4
PMID 29721353
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Our review suggests that most autism spectrum disorder (ASD) risk factors are connected, either directly or indirectly, to immunoexcitotoxicity. Chronic brain inflammation is known to enhance the sensitivity of glutamate receptors and interfere with glutamate removal from the extraneuronal space, where it can trigger excitotoxicity over a prolonged period. Neuroscience studies have clearly shown that sequential systemic immune stimulation can activate the brain's immune system, microglia, and astrocytes, and that with initial immune stimulation, there occurs CNS microglial priming. Children are exposed to such sequential immune stimulation via a growing number of environmental excitotoxins, vaccines, and persistent viral infections. We demonstrate that fluoride and aluminum (Al) can exacerbate the pathological problems by worsening excitotoxicity and inflammation. While Al appears among the key suspicious factors of ASD, fluoride is rarely recognized as a causative culprit. A long-term burden of these ubiquitous toxins has several health effects with a striking resemblance to the symptoms of ASD. In addition, their synergistic action in molecules of aluminofluoride complexes can affect cell signaling, neurodevelopment, and CNS functions at several times lower concentrations than either Al or fluoride acting alone. Our review opens the door to a number of new treatment modes that naturally reduce excitotoxicity and microglial priming.

Citing Articles

Immunoexcitoxicity as the possible major pathophysiology behind multiple sclerosis and other autoimmune disorders.

Blaylock R Surg Neurol Int. 2025; 16:26.

PMID: 39926461 PMC: 11799683. DOI: 10.25259/SNI_1114_2024.


Reversal of Autism Symptoms among Dizygotic Twins through a Personalized Lifestyle and Environmental Modification Approach: A Case Report and Review of the Literature.

DAdamo C, Nelson J, Miller S, Rickert Hong M, Lambert E, Tallman Ruhm H J Pers Med. 2024; 14(6).

PMID: 38929862 PMC: 11205016. DOI: 10.3390/jpm14060641.


Additive aluminum as a cause of induced immunoexcitoxicity resulting in neurodevelopmental and neurodegenerative disorders: A biochemical, pathophysiological, and pharmacological analysis.

Blaylock R Surg Neurol Int. 2024; 15:171.

PMID: 38840623 PMC: 11152537. DOI: 10.25259/SNI_296_2024.


Progress in research on the role of fluoride in immune damage.

Zhu S, Wei W Front Immunol. 2024; 15:1394161.

PMID: 38807586 PMC: 11130356. DOI: 10.3389/fimmu.2024.1394161.


Taurine as a potential therapeutic agent interacting with multiple signaling pathways implicated in autism spectrum disorder (ASD): An in-silico analysis.

Bhandari R, Varma M, Rana P, Dhingra N, Kuhad A IBRO Neurosci Rep. 2023; 15:170-177.

PMID: 37711998 PMC: 10497788. DOI: 10.1016/j.ibneur.2023.08.2191.


References
1.
Kumar V, Gill K . Oxidative stress and mitochondrial dysfunction in aluminium neurotoxicity and its amelioration: a review. Neurotoxicology. 2014; 41:154-66. DOI: 10.1016/j.neuro.2014.02.004. View

2.
Khan Z, Combadiere C, Authier F, Itier V, Lux F, Exley C . Slow CCL2-dependent translocation of biopersistent particles from muscle to brain. BMC Med. 2013; 11:99. PMC: 3616851. DOI: 10.1186/1741-7015-11-99. View

3.
Rose S, Melnyk S, Pavliv O, Bai S, Nick T, Frye R . Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl Psychiatry. 2012; 2:e134. PMC: 3410618. DOI: 10.1038/tp.2012.61. View

4.
Ghiani C, Beltran-Parrazal L, Sforza D, Malvar J, Seksenyan A, Cole R . Genetic program of neuronal differentiation and growth induced by specific activation of NMDA receptors. Neurochem Res. 2006; 32(2):363-76. DOI: 10.1007/s11064-006-9213-9. View

5.
Estes M, Kimberley McAllister A . Immune mediators in the brain and peripheral tissues in autism spectrum disorder. Nat Rev Neurosci. 2015; 16(8):469-86. PMC: 5650494. DOI: 10.1038/nrn3978. View